| For: | Nie LJ, Wang GX, Yang XY, Sun J, Cao YT, Lou Y, Lu YF, Yu JY, Zhou XQ. Lianhe Xiaozhi ointment ameliorates metabolic dysfunction-associated steatotic liver disease via peroxisome proliferator-activated receptor alpha pathway activation. World J Gastroenterol 2026; 32(9): 114544 [PMID: 41810443 DOI: 10.3748/wjg.v32.i9.114544] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v32/i9/114544.htm |
| Number | Citing Articles |
| 1 |
Bin Li, Yu-Meng Liu, Rui-Xi Ming, Tian-Ci Tang. Letter to the Editor: Lianhe Xiaozhi ointment for metabolic dysfunction-associated steatotic liver disease - a gut-liver-brain axis perspective. World Journal of Gastroenterology 2026; 32(32): 118636 doi: 10.3748/wjg.118636
|
| 2 |
Yasser Fouad, Ebada M Said, Lubna Kamani, Hisham R El-Khayat. Reviving peroxisome proliferator-activated receptors in fatty liver disease: From herbal formula to nuclear receptor targeting. World Journal of Gastroenterology 2026; 32(35): 119168 doi: 10.3748/wjg.119168
|